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Summary.-It is suggested that the proximate carcinogenic forms of dialkylnitro-
samines are their oxidation products, which retain the alkylnitrosamino moiety, but
have acquired a carbonyl function as a result of omega or beta oxidation of an alkyl
group. Such metabolites resemble the locally acting carcinogenic " nitrosamides "
and probably have become multifunctional. Their functional groups, being in close
proximity, could ensure binding in a concerted manner with apposite reactive
centres of chromatin to form a firm bridge, for example, between an amino group of
nucleic acid base and thiols of protein chains.
THE carcinogenic action of dialkyl-
nitrosamines and related compounds has
been believed to be related to their
alkylation of nucleic acid bases and
possibly of other cellular macromolecules,
the alkylating moiety being released in
the course of the oxidative metabolism
of these compounds (Magee and Barnes,
1967; Druckrey, Preussmann and Ivan-
kovic, 1969).
However, in subsequent studies, many
workers found that the degree of alkyla-
tion of nucleic acid bases in various
organs, by various nitroso compounds
other than dimethylnitrosamine (DMN),
did not correlate with the localization of
tumours induced by the respective com-
pounds (Schoental, 1967; 1969; Swann
and Magee, 1968, 1971; Lijinsky et al.,
1972; Goth and Rajewsky, 1972, and
others). A possibility that the mono
alkylnitrosamino moiety may be involved
in the biological actions of nitrosamines
has been considered by Heath (1962) and
rejected.
It is unfortunate that DMN has been
used mainly in studies of the mechanism
of action ofnitrosamines; oxidation ofthe
a carbon leads to very unstable inter-
mediates, which decompose with the
release of nitrogen, and an alkylating
moiety. Moreover, when searching for
the alkylated bases the nucleic acids have
often been subjected to strong acid
hydrolysis, a procedure which might
decompose addition and other product(s)
which may be also present in the isolated
nucleic acid fractions.
The ethyl homologue, diethylnitro-
samine (DEN), is a much less damaging
agent for the liver, though very effective
as a carcinogen. It may be significant
that the degree of ethylation of nucleic
acid bases occurs to a much lesser extent
than the respective methylations (Goth
and Rajewsky, 1972). (The ratio is
1/30 to 1/100.)
The involvement of the nitrosamino
moiety has been suggested also as regards
the mutagenic action of nitroso com-
pounds (Rosenkranz, Rosenkranz and
Schmidt, 1969). The problem has been
discussed fully by Magee, who concluded:
"It is possible that the nitroso compounds
owe their biological activity to these
alkylation reactions, but this is not
established, and other cellular interac-
tions may be involved " (Magee, 1969).
I suggest that the carcinogenic action
of alkylnitrosamines (A) is mediated by
their respective alkylnitrosamino alde-
hydes (C), which may be intermediateTHE MECHANISMS OF ACTION OF NITROSO-CARCINOGENS
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(A) Parent dialkylnitrosamines.
(B) Hydroxymethyl metabolites.
(C) Postulated aldehydic metabolites which are likely to be intermediate oxidation products
between (B) and (D).
(D) Carboxylic metabolites.
FIG. 1. Metabolites of (lialkylnitrosamines.
oxidation products between the alcoholic
(B) and carboxylic (D) metabolites (Fig.
1). Such metabolic aldehydes would re-
semble in action the alkylnitrosourethanes
(Schoental, 1966).
The evidence that the alkylnitros-
amino moiety can survive metabolic
oxidation is based on the published
results of metabolic studies. Already in
1964, polar metabolites which retained
the nitrosamino moiety had been detected
in the urine of rats given a large dose
(1000 mg/kg body weight) of dibutyl-
nitrosamine (Druckrey et al., 1964). More
recently, Okada and Suzuki (1972) identi-
fied butyl(3-carboxypropyl)nitrosamine
and butyl(3-carboxy-2-hydroxypropyl)ni-
trosamine as the main urinary meta-
bolites of the bladder carcinogen, butyl(4-
hydroxybutyl)nitrosamine, in the rat. The
evidence that the alkylnitrosamino moiety
can survive metabolic oxidation has been
confirmed in the case of several symmetri-
cal dialkylnitrosamines, having C2 to C5
carbons in the alkyl chains. Among the
rat urinary metabolites of these com-
pounds products of w oxidation of the
alkyls in the form of hydroxylic and
carboxylic derivatives have been identi-
fied. In the case of di-n-pentylnitros-
amine, shortening of an alkyl chain
occurred; one of its metabolites was
identified as 7N-n-pentyl-N-nitroso-N-n-
propionic acid (Blattmann and Preuss-
mann, 1973).
The fact that alcoholic and carboxylic
nitrosamino metabolites are excreted in
the urine suggests that the respective
aldehydo and keto derivatives, which
would be expected to be formed by the
action of alcohol dehydrogenase (an en-
zyme known to be present mainly in the
liver and in the kidneys) should be also
searched for. However, the aldehydic
metabolites are likely to be very reactive
and would probably become bound close
to the site of formation by reacting with
nucleophilic centres of cellular macro-
molecules. The reactivity of the alde-
hydic carbonyl may exceed that of the
ester in N-alkyl-nitrosourethanes, which
are known to interact with sulphydryls
and free amino groups (Schoental, 1966).
A hypothetical scheme of interaction of
the aldehydic derivatives with chromatin
is represented in Fig. 2.
It is not unlikely that at a particular
stage of the cell's existence chromatin
may assume a conformation in which a
free amino group of a nucleic acid base
could be present in close vicinity to two
thiols of peptide chains. Such a con-
formation would allow the aldehydic
carbonyl to condense with the amino
group to form a Schiff base type of bond,
while the thiols could reduce the nitroso
group and form covalent bonds. As a
result, a firm " bridge " (possibly in the
form of a 6 or 7 membered ring) would
bind the nucleoprotein with the nucleic
acid. Such binding may be irreversible,
irreparable, and have long lasting " fate-
ful" consequences. Some such change
would be expected, especially in the
case of carcinogens which can induce
tumours even with a single dose after a
long latent period.
Yet, though the carcinogen circulates
throughout the whole body and comes in
contact with innumerable cells the "fate-
ful " consequences are a rare cellular
event. This might be due to the stringent
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R H, R' CH3, [N-methyl-N-nitrosoformaldehyde];
R =OC2H5, R' = CH3, N-methyl-N-nitrosourethane;
R =NH2, R' = CH3, N-methvl-N-nitrosourea;
R H, R' = C2H5, [N-ethyl-N-nitrosoformaldehyde];
R = OC2H5, R' = C2H5, N-ethyl-N-nitrosourethane;
R = NH2, R' = C2H5, N-ethyl-IN-nitrosourea etc.
FIG. 2.-Hypothetical scheme for the interaction of chromatin w%vith alkylnitroso compounds.
conditions under which such interactions
could take place: the relevant part of the
nucleic acid base must be accessible and
the particular sulphur containing nucleo-
histones, or other specific protein, must
be in reduced form at the time of en-
counter with the activated molecule of
the carcinogen.
The spatial distribution of the specific
reactive centres in chromatin and their
accessibility (Mirsky, 1971) probably de-
termine that only compounds of appro-
priate size and geometry, and having
apposite functional groups, could fit and
interact with it in a concerted manner.
When bulky substituents are present,
e.g. R' tert-butyl, steric factors may
prevent the formation of such a bridge.
Similarly, when the alkyls are long
chains, as in the case of n-dibutylnitros-
amine, these have to undergo appropriate
shortening by decarboxylation of one of
their oxidized alkyls before the compound
can react and fit into the critical space.
(Hence its carcinogenic action becomes
apparent in the bladder.)
The polar, water soluble, metabolites
are excreted mostly in the form of the
non carcinogenic glucuronides; the part
that is carried in the blood stream in
unconjugated form can exert carcinogenic
action only at sites where their concen-
tration overcomes their unfavourable dis-
tribution characteristics and allows enough
of the compound to penetrate into the
cells, e.g. in the kidney or in the bladder.
Some of the metabolites are indeed
known to be carcinogenic, though not
toxic even in large doses. According to
Magee and Barnes (1967) for rats, the
LD50 of N-nitrosodiethylamine is 216
mg/kg body weight, while that of N-
nitroso - ethyl - 2 - hydroxyethylamine is
more than 7500 mgfkg; the LD50 of
NV-nitroso-di-n-butylamine is 1200 mg/kg
while that of N-nitrosobutyl-4-hydroxy-
butylamine is 1800 mg/kg body weight.
It may be significant that the gluco-
side, cycasin, has to be hydrolysed in
order to exert carcinogenic action (La-
queur and Spatz, 1968); its aglycone,
methylazoxymethanol,
Ci3-N NN CH20H
0
would be expected to undergo oxidation
to methylazoxyformaldehyde and react
at similar cellular sites, in a similar
manner, to the aldehydic derivatives of
nitrosamines.
I thank Professor E. Cotchin for kind
hospitality in his Department and Pro-
fessor P. N. Magee for helpful criticism.
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